Patent ID: 11918636
Assignee: SCANDINAVIAN BIOPHARMA HOLDING AB, C/O ETVAX AB
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  Y | IPC A

Claim 5:
6. The method according to claim 1, wherein the vaccine comprises per unit dose:
a) inactivated E. coli expressing CFA/I in an amount of 415-1245 Mg of CFA/I;
b) inactivated E. coli expressing CS3 in an amount of 1485-4455 μg of CS3;
c) inactivated E. coli expressing CS5 in an amount of 255-765 μg of CS5; and
d) inactivated E. coli expressing CS6 in an amount of 60-180 μg of CS6.